Non Invasive Prenatal Testing Market: Consumables, Method
Non Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021
(firmenpresse) - According to the new market research report & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets
To Get 10% Customization on Report (at) https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=145607690
The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period.
The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.
Browse and in-depth TOC on
110 - Tables
48 - Figures
150 - Pages
For Bundle Reports (at) https://www.marketsandmarkets.com/RequestBundleReport.asp?id=145607690
On the basis of product, the market is classified into consumables and instruments. The consumable segment is further divided into assay kits & reagents and disposables. The instruments segment is divided into ultrasound devices, NGS systems, PCR instruments, microarrays, and other instruments. In 2016, the consumables segment accounted for the largest share of the market. The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT.
To Get 10% Customization on Report (at) https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=145607690
Based on application, the market is segmented into Trisomy, microdeletion syndrome, and other applications. Trisomy forms the largest and fastest-growing application segment of the global market. This is attributed to factors such as increasing maternal age and rising incidence of chromosomal abnormalities.
The market is highly fragmented with several big and emerging players. Key market players include GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst(at)https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=145607690
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.08.2019 - 05:55 Uhr
Sprache: Deutsch
News-ID 1551723
Anzahl Zeichen: 3124
contact information:
Contact person: Rama Sharma
Town:
Pune
Phone: 08886006441
Kategorie:
Healthcare & Medical
Typ of Press Release: Financial
type of sending: send
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 400 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Non Invasive Prenatal Testing Market: Consumables, Method
"
steht unter der journalistisch-redaktionellen Verantwortung von
MarketsandMarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
